SUVEN LIFESCIENCES Plunges by 5%; BSE HEALTHCARE Index Down 1.0%
July 24, 2019 10:44 AM

SUVEN LIFESCIENCES share price has plunged 5% and is presently trading at Rs 241.

Meanwhile, the BSE HEALTHCARE Index is at 12,810 (down 1.0%).

Among the top losers in the BSE HEALTHCARE Index today is SUVEN LIFESCIENCES (down 5.1%).

TORRENT PHARMA (up 4.2%) and BLISS GVS PHARMA (up 2.3%) are among the top gainers today.

Over the last one year, SUVEN LIFESCIENCES has moved up from Rs 230 to Rs 241, registering a gain of Rs 11 (up 4.7%)..

The BSE HEALTHCARE has moved down from 13,760 to 12,810, loss of 950 points (down 6.9%) during the last 12 months.

The top gainers among the BSE HEALTHCARE Index stocks during this same period were PROCTER & GAMBLE HEALTH (up 101.3%), DIVIS LABORATORIES (up 48.0%) and APOLLO HOSPITALS (up 40.5%).

What About the Benchmark Indices?

The BSE Sensex is at 38,103 (down 0.6%). The top gainers among the BSE Sensex stocks today are HDFC (up 1.4%), HUL (up 0.4%) and YES BANK (up 0.4%). Other gainer include SBI (up 0.2%). The most traded stocks in the BSE Sensex are YES BANK and SBI.

In the meantime, NSE Nifty is at 11,360 (down 0.9%). HDFC (up 1.1%) is among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved up from 36,719 to 38,103, registering a gain of 1,384 points (up 2.8%).

SUVEN LIFESCIENCES Financial Update...

SUVEN LIFESCIENCES net profit stood at Rs 680 million for the quarter ended March 2019, compared to a profit of Rs 252 million a year ago. Net Sales rose 96.3% to Rs 2.5 billion during the period as against Rs 1.3 billion in January-March 2018.

For the year ended March 2019, SUVEN LIFESCIENCES reported 29.7% decrease in net profit to Rs 869.0 million compared to net profit of Rs 1.2 billion during FY18.

Revenue of the company grew 6.1% to Rs 7 billion during FY19.

The current Price to earnings ratio of SUVEN LIFESCIENCES, based on rolling 12 month earnings, stands at 19.2x.